IP Library Granted Patent US 9,709,521
Granted Patent B2
US 9,709,521 · App. 14/007,234 · Granted Jul 18, 2017

System and method for measuring an analyte in a sample and correcting for interferents

Inventors: David Matzinger (Menlo Park, CA); Maria Teodorczyk (San Jose, CA)
Assignee: Cilag GmbH International
G01N27/3274A61B5/14532A61B2562/0295
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,709,521
App. No.
14/007,234
Granted
Jul 18, 2017
Kind
B2
Abstract

Methods and systems to apply a plurality of test voltages to the test strip and measure a current transient output resulting from an electrochemical reaction in a test chamber of the test strip so that a glucose concentration can be determined that account for interferent substances in the body fluid sample. A method of determining blood glucose concentration with a glucose measurement system that includes a test strip and test meter. The test meter has a microcontroller configured to apply a plurality of test voltages to the test strip and measure a current transient output resulting from an electrochemical reaction in a test chamber of the test strip.

Claims (618)

1. A method of determining blood glucose concentration with a glucose measurement system that includes a test strip and test meter, the test meter having a microcontroller configured to apply a plurality of test voltages comprising first, second and third test voltages to the test strip and measure a current transient output resulting from an electrochemical reaction in a test chamber of the test strip, the method comprising:

inserting the test strip into a strip port connector of the test meter to connect at least two electrodes of the test strip to a strip measurement circuit;

initiating a test sequence after deposition of a sample by causing the first test voltage to be applied, the first test voltage causing a transformation of analytes in the sample from one form to a different form;

switching a first test voltage to a second test voltage different than the first test voltage;

changing the second test voltage to a third test voltage different from the second voltage;

measuring a second current output of the current transient from the electrodes after the changing from the second test voltage to the third test voltage;

estimating a current that approximates a steady state current output of the current transient after the third test voltage is maintained at the electrodes;

calculating a blood glucose concentration based on the first, second and third current output of the current transient with an equation of the form:

G

1

=

(

i

r

i

l

)

p

(

a

i

2

CORR

-

zgr

)

;

where: G 1 comprises a glucose concentration;

i

r

=

t

=

4.4

t

=

5

i

(

t

)

;

i

l

=

t

=

1.4

t

=

4

i

(

t

)

;

i

2

(

Corr

)

=

(

i

4.1

+

b

i

5

-

c

i

1.1

i

4.1

+

b

i

5

)

i

r

where:

a, b, c, p, zgr comprise manufacturing parameters;

i 4.1 comprises the current measured at about 4.1 seconds after initiation of test sequence;

i 5 comprises the current measured at about 5 seconds after initiation of test sequence;

i 1.1 comprises the current measured at about 1.1 seconds after initiation of test sequence; and

correcting the blood glucose concentration with an equation of the form:

G corr =G 1 *( A+B*i 1.1 )

where G corr comprises a corrected blood glucose concentration and coefficients A and B comprise empirically derived coefficients.

2. The method of claim 1 , in which the coefficients A and B comprise approximately 1.004 and approximately 0.0077, respectively.

3. A method of determining blood glucose concentration with a glucose measurement system that includes a test strip and test meter, the test meter having a microcontroller configured to apply a plurality of test voltages comprising a first test voltage, a second test voltage, and a third test voltage to the test strip and measure a current transient output resulting from an electrochemical reaction in a test chamber of the test strip, the method comprising:

inserting the test strip into a strip port connector of the test meter to connect at least two electrodes of the test strip to a strip measurement circuit;

initiating a test sequence after deposition of a sample by applying the first test voltage;

causing a transformation of analytes in the sample from one form to a different form;

switching the first test voltage to a second test voltage different than the first test voltage;

changing the second test voltage to a third test voltage different from the second voltage;

measuring a second current output of the current transient from the electrodes after the changing from the second test voltage to the third test voltage;

estimating approximate steady state current output of the current transient after the third test voltage is maintained at the electrodes;

calculating a blood glucose concentration based on the first, second and third current output of the current transient with an equation of the form:

G

1

=

(

i

r

i

l

)

p

(

a

i

2

CORR

-

zgr

)

;

where: G 1 comprises a glucose concentration;

i

r

=

t

=

4.4

t

=

5

i

(

t

)

;

i

l

=

t

=

1.4

t

=

4

i

(

t

)

;

i

2

(

Corr

)

=

(

i

4.1

+

b

i

5

-

c

i

1.1

i

4.1

+

b

i

5

)

i

r

where:

a, b, c, p, zgr comprise manufacturing parameters;

i 4.1 comprises the current measured at about 4.1 seconds after initiation of test sequence;

i 5 comprises the current measured at about 5 seconds after initiation of test sequence;

i 1.1 comprises the current measured at about 1.1 seconds after initiation of test sequence; and

correcting the blood glucose concentration with an equation of the form:

G corr =G 1 *( C+D*i 1.1 +E *( i 1.1 ) 2 )

where G corr comprises a corrected blood glucose concentration and coefficients C, D and E comprise empirically derived coefficients.

4. The method of claim 3 , in which the step of switching comprises changing the polarity of the second test voltage with respect to the first test voltage.

5. The method of claim 3 , in which the deriving of the first corrected glucose concentration comprises calculating with equations of the form:

G

1

=

(

i

r

i

l

)

p

(

a

i

2

CORR

-

zgr

)

;

where: G 1 comprises a glucose concentration;

i

r

=

t

=

4.4

t

=

5

i

(

t

)

;

i

l

=

t

=

1.4

t

=

4

i

(

t

)

;

i

2

(

Corr

)

=

(

i

4.1

+

b

i

5

-

c

i

1.1

i

4.1

+

b

i

5

)

i

r

where:

a, b, c, p, zgr comprise manufacturing parameters;

i 4.1 comprises the current measured at about 4.1 seconds after initiation of test sequence;

i 5 comprises the current measured at about 5 seconds after initiation of test sequence;

i 1.1 comprises the current measured at about 1.1 seconds after initiation of test sequence; and

G corr1 =G 1 *( A+B*i 1.1 )

where G corr1 comprises a first corrected blood glucose concentration and coefficients A and B comprise empirically derived coefficients.

6. The method of claim 3 , in which the deriving of the second corrected glucose concentration comprises calculating with equations of the form

G

1

=

(

i

r

i

l

)

p

(

a

i

2

CORR

-

zgr

)

;

where: G 1 comprises a glucose concentration;

i

r

=

t

=

4.4

t

=

5

i

(

t

)

;

i

l

=

t

=

1.4

t

=

4

i

(

t

)

;

i

2

(

Corr

)

=

(

i

4.1

+

b

i

5

-

c

i

1.1

i

4.1

+

b

i

5

)

i

r

where:

a, b, c, p, zgr comprise manufacturing parameters;

i 4.1 comprises the current measured at about 4.1 seconds after initiation of test sequence;

i 5 comprises the current measured at about 5 seconds after initiation of test sequence;

i 1.1 comprises the current measured at about 1.1 seconds after initiation of test sequence; and

correcting the blood glucose concentration with an equation of the form:

G corr2 =G 1 *( C+D*i 1.1 +E *( i 1.1 ) 2 )

where G corr2 comprises a corrected blood glucose concentration and coefficients C, D and E comprise empirically derived coefficients.

7. The method of claim 3 , in which the measuring of the first current output comprises measuring a current output of the at least two electrodes at about 1.1 seconds after initiation of test sequence.

8. The method of claim 3 , in which the measuring of the second current output comprises measuring a current output of the at least two electrodes at about 4.1 seconds after initiation of test sequence.

9. The method of claim 3 , in which the estimating of the steady state current output comprises measuring a current output of the at least two electrodes at about 5 seconds after initiation of test sequence.

10. The method of claim 3 , in which the coefficients A, B, C, D, and E comprise approximately 1.004, approximately 0.0077, approximately 0.889, approximately 0.0220 and approximately −0.00036, respectively.

11. The method of claim 5 , in which the coefficients A and B comprise approximately 1.004 and approximately 0.0077, respectively.

12. The method of claim 5 , in which the coefficients C, D, and E comprise approximately 0.889, approximately 0.0220 and approximately −0.00036, respectively.

13. The method of claim 5 , in which the manufacturing parameter a comprises approximately 0.192, b comprises approximately 0.68, c comprises approximately 2, p comprises approximately 0.52, and zgr comprises approximately 2.

14. The method of claim 3 , in which the threshold percentage is greater than 10% difference in glucose concentrations.

15. A blood glucose measurement system comprising:

an analyte test strip including:

a substrate having a reagent disposed thereon;

at least two electrodes proximate the reagent in test chamber;

an analyte meter including:

a strip port connector disposed to connect to the two electrodes;

a power supply; and

a microcontroller electrically coupled to the strip port connector and the power supply, the microcontroller programmed to,

apply a first test voltage;

switch the first test voltage to a second test voltage different than the first test voltage;

change the second test voltage to a third test voltage different from the second test voltage,

measure a second current output of the current transient from the electrodes after the change from the second test voltage to the third test voltage,

estimate a current that approximates a steady state current output of the current transient after the third test voltage is maintained at the electrodes, and

determine a glucose concentration G 1 and a corrected glucose concentration G corr to account for interfering agents so that at least 97% of corrected test results are within respective bias criterion of ±10 mg/dL at 65 mg/dL, 240 mg/dL, or at 450 mg/dL as compared to reference YSI data; ±12 mg/dL at 65 mg/dL, 240 mg/dL, or 450 mg/dL as compared to reference YSI data; and ±15 mg/dL at 65 mg/dL, 240 mg/dL, or 450 mg/dL as compared to reference YSI data, the glucose concentration and the corrected glucose concentration based on the first, second and third current output and being derived from the following equations:

G

1

=

(

i

r

i

l

)

p

(

a

i

2

CORR

-

zgr

)

;

where: G 1 comprises a glucose concentration;

i

r

=

t

=

4.4

t

=

5

i

(

t

)

;

i

l

=

t

=

1.4

t

=

4

i

(

t

)

;

i

2

(

Corr

)

=

(

i

4.1

+

b

i

5

-

c

i

1.1

i

4.1

+

b

i

5

)

i

r

where:

a, b, c, p, zgr comprise manufacturing parameters;

i 4.1 comprises the current measured at about 4.1 seconds after initiation of test sequence;

i 5 comprises the current measured at about 5 seconds after initiation of test sequence;

i 1.1 comprises the current measured at about 1.1 seconds after initiation of test sequence; and

G corr =G 1 *( C+D*i 1.1 +E *( i 1.1 ) 2 )

where G corr comprises a corrected blood glucose concentration and coefficients C, D and E comprise empirically derived coefficients.

16. The system of claim 15 , in which the manufacturing parameters a, b, c, p, zgr are such that a comprises approximately 0.192, b comprises approximately 0.68, c comprises approximately 2, p comprises approximately 0.52 and zgr comprises approximately 2.

17. The system of claim 15 , in which the coefficients C, D, and E comprise approximately 0.889, approximately 0.0220 and approximately −0.00036, respectively.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 051050/0413 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2013
From: MATZINGER, DAVID; TEODORCZYK, MARIA
To: CILAG GMBH INTERNATIONAL
Reel/Frame 031271/0412 →
Continuity (2)
Provisional Application 61467719 · Mar 25, 2011
Related Publication 20140311924A1 · Oct 23, 2014